Volver al buscador
FDAFDA · Alimentos y medicamentos·N.º oficial Z-1902-2017

Dressing M/U XL, P/N 02344 Product Usage: These products are sterile dressings used as an insulation barrier between the Polar Care cold therapy pad and the skin. Sterile dressings are typically applied in a non-sterile environment after post-op and on occasion may be applied in a sterile environment. Breg has determined that a small percentage (approximately 0.22%) of these products may have been sent with unsealed pouches by the contract manufacturer. Customers will be contacted and instructed to inspect their inventory for any product with unsealed pouches and discard them.

Publicado el 10 de mayo de 2017 · Inicio del retiro: 30 de marzo de 2017

Resumen

FDA registra el retiro Z-1902-2017 de dispositivos médicos de Clase II, publicado el 10 de mayo de 2017 e iniciado el 30 de marzo de 2017. Empresa responsable: Breg Inc; Estado: Finalizado; Cantidad reportada: 2,609 units total; Lote: D163474, D163544. La Clase II indica posibles consecuencias temporales o médicamente reversibles, o una probabilidad remota de consecuencias graves.

Estado reportado al momento de publicación: Terminated — openFDA actualiza semanalmente y este campo no refleja el estado más reciente. Confirma siempre con la fuente oficial.

Qué peligro representa

They may not have been sealed prior to sterilization. Products with unsealed pouches will be non-sterile.

Qué hacer

Voluntary: Firm initiated · Letter

Recibe un correo cuando FDA publique un retiro como este

Gratis. Solo te escribimos cuando hay un retiro nuevo que coincide. Te das de baja con un clic.

Detalles del retiro

Fabricante
Breg Inc
Distribuidor
US Nationwide Distribution
Lote
D163474, D163544
Clasificación de riesgo
Class II
Área (FDA)
device
País
United States

Retiros relacionados

Preguntas sobre este retiro

¿Dressing M/U XL, P/N 02344 Product Usage: These products are sterile dressings used as an insulation barrier between the Polar Care cold therapy pad and the skin. Sterile dressings are typically applied in a non-sterile environment after post-op and on occasion may be applied in a sterile environment. Breg has determined that a small percentage (approximately 0.22%) of these products may have been sent with unsealed pouches by the contract manufacturer. Customers will be contacted and instructed to inspect their inventory for any product with unsealed pouches and discard them. fue retirado del mercado?

Sí. FDA publicó el retiro Z-1902-2017 el 10 de mayo de 2017. Peligro reportado: They may not have been sealed prior to sterilization. Products with unsealed pouches will be non-sterile.

¿Qué debo hacer si tengo este producto?

Voluntary: Firm initiated · Letter